annual cash & cash equivalents:
$412.50M+$218.98M(+113.16%)Summary
- As of today (September 14, 2025), INVA annual cash & cash equivalents is $412.50 million, with the most recent change of +$218.98 million (+113.16%) on December 31, 2024.
- During the last 3 years, INVA annual cash & cash equivalents has risen by +$210.97 million (+104.69%).
- INVA annual cash & cash equivalents is now -11.32% below its all-time high of $465.13 million, reached on December 31, 2013.
Performance
INVA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$497.73M+$50.85M(+11.38%)Summary
- As of today (September 14, 2025), INVA quarterly cash & cash equivalents is $497.73 million, with the most recent change of +$50.85 million (+11.38%) on June 30, 2025.
- Over the past year, INVA quarterly cash & cash equivalents has increased by +$280.73 million (+129.37%).
- INVA quarterly cash & cash equivalents is now -1.66% below its all-time high of $506.15 million, reached on September 30, 2013.
Performance
INVA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INVA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +113.2% | +129.4% |
| 3 y3 years | +104.7% | +75.5% |
| 5 y5 years | +17.6% | +19.3% |
INVA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.2% | at high | +245.5% |
| 5 y | 5-year | at high | +113.2% | at high | +1050.4% |
| alltime | all time | -11.3% | +1053.9% | -1.7% | +1050.4% |
INVA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $497.73M(+11.4%) |
| Mar 2025 | - | $446.88M(+8.3%) |
| Dec 2024 | $412.50M(+113.2%) | $412.50M(+58.3%) |
| Sep 2024 | - | $260.63M(+20.1%) |
| Jun 2024 | - | $217.00M(+21.7%) |
| Mar 2024 | - | $178.36M(-7.8%) |
| Dec 2023 | $193.51M(-33.5%) | $193.51M(+7.5%) |
| Sep 2023 | - | $180.00M(+4.0%) |
| Jun 2023 | - | $173.03M(+20.1%) |
| Mar 2023 | - | $144.05M(-50.5%) |
| Dec 2022 | $291.05M(+44.4%) | $291.05M(-3.3%) |
| Sep 2022 | - | $301.07M(+6.2%) |
| Jun 2022 | - | $283.58M(+30.8%) |
| Mar 2022 | - | $216.80M(+7.6%) |
| Dec 2021 | $201.53M(-18.2%) | $201.53M(+49.2%) |
| Sep 2021 | - | $135.12M(+212.3%) |
| Jun 2021 | - | $43.27M(-84.7%) |
| Mar 2021 | - | $282.89M(+14.8%) |
| Dec 2020 | $246.49M(-29.7%) | $246.49M(-48.6%) |
| Sep 2020 | - | $479.19M(+14.9%) |
| Jun 2020 | - | $417.15M(+8.6%) |
| Mar 2020 | - | $383.95M(+9.4%) |
| Dec 2019 | $350.85M(+205.3%) | $350.85M(+18.0%) |
| Sep 2019 | - | $297.20M(+19.0%) |
| Jun 2019 | - | $249.66M(+29.9%) |
| Mar 2019 | - | $192.18M(+67.2%) |
| Dec 2018 | $114.91M(-11.0%) | $114.91M(+107.1%) |
| Sep 2018 | - | $55.48M(-48.4%) |
| Jun 2018 | - | $107.54M(+90.5%) |
| Mar 2018 | - | $56.46M(-56.3%) |
| Dec 2017 | $129.07M(-14.2%) | $129.07M(-23.3%) |
| Sep 2017 | - | $168.19M(+24.0%) |
| Jun 2017 | - | $135.63M(-20.1%) |
| Mar 2017 | - | $169.81M(+12.9%) |
| Dec 2016 | $150.43M(-19.7%) | $150.43M(+1.0%) |
| Sep 2016 | - | $148.97M(-3.2%) |
| Jun 2016 | - | $153.87M(-8.5%) |
| Mar 2016 | - | $168.19M(-10.2%) |
| Dec 2015 | $187.28M | $187.28M(-9.2%) |
| Sep 2015 | - | $206.19M(-10.1%) |
| Jun 2015 | - | $229.26M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $251.14M(+4.4%) |
| Dec 2014 | $240.50M(-48.3%) | $240.50M(-10.5%) |
| Sep 2014 | - | $268.71M(-22.9%) |
| Jun 2014 | - | $348.71M(-6.0%) |
| Mar 2014 | - | $370.92M(-20.3%) |
| Dec 2013 | $465.13M(+87.2%) | $465.13M(-8.1%) |
| Sep 2013 | - | $506.15M(+14.3%) |
| Jun 2013 | - | $443.01M(-3.5%) |
| Mar 2013 | - | $459.06M(+84.7%) |
| Dec 2012 | $248.49M(+3.1%) | $248.49M(-9.1%) |
| Sep 2012 | - | $273.44M(-7.5%) |
| Jun 2012 | - | $295.49M(+47.6%) |
| Mar 2012 | - | $200.16M(-16.9%) |
| Dec 2011 | $240.91M(-22.2%) | $240.91M(-15.1%) |
| Jun 2011 | - | $283.89M(-3.4%) |
| Mar 2011 | - | $293.82M(-5.1%) |
| Dec 2010 | $309.63M(+54.4%) | $309.63M(+60.9%) |
| Sep 2010 | - | $192.47M(-8.7%) |
| Jun 2010 | - | $210.69M(-6.5%) |
| Mar 2010 | - | $225.45M(+46.2%) |
| Sep 2009 | - | $154.23M(-12.2%) |
| Jun 2009 | - | $175.68M(-1.8%) |
| Mar 2009 | - | $178.88M(-10.8%) |
| Dec 2008 | $200.60M(-22.0%) | $200.60M(-8.3%) |
| Sep 2008 | - | $218.84M(-5.8%) |
| Jun 2008 | - | $232.35M(-9.8%) |
| Mar 2008 | - | $257.67M(+87.3%) |
| Sep 2007 | - | $137.54M(-8.7%) |
| Jun 2007 | - | $150.65M(-18.4%) |
| Mar 2007 | - | $184.63M(-17.3%) |
| Sep 2006 | - | $223.25M(-7.9%) |
| Jun 2006 | - | $242.44M(-6.2%) |
| Mar 2006 | - | $258.60M(+50.1%) |
| Sep 2005 | - | $172.32M(-14.9%) |
| Jun 2005 | - | $202.38M(-12.7%) |
| Mar 2005 | - | $231.83M(-9.8%) |
| Dec 2004 | $257.14M(+619.3%) | $257.14M(+47.5%) |
| Sep 2004 | - | $174.34M(-7.3%) |
| Jun 2004 | - | $188.01M(+154.5%) |
| Mar 2004 | - | $73.87M |
| Dec 2003 | $35.75M(-67.1%) | - |
| Dec 2002 | $108.80M | - |
FAQ
- What is Innoviva, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Innoviva, Inc.?
- What is Innoviva, Inc. annual cash & cash equivalents year-on-year change?
- What is Innoviva, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Innoviva, Inc.?
- What is Innoviva, Inc. quarterly cash & cash equivalents year-on-year change?
What is Innoviva, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of INVA is $412.50M
What is the all time high annual cash & cash equivalents for Innoviva, Inc.?
Innoviva, Inc. all-time high annual cash & cash equivalents is $465.13M
What is Innoviva, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, INVA annual cash & cash equivalents has changed by +$218.98M (+113.16%)
What is Innoviva, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of INVA is $497.73M
What is the all time high quarterly cash & cash equivalents for Innoviva, Inc.?
Innoviva, Inc. all-time high quarterly cash & cash equivalents is $506.15M
What is Innoviva, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, INVA quarterly cash & cash equivalents has changed by +$280.73M (+129.37%)